Punch & Associates Investment Management »

Peregrine Pharmaceuticals shares owned by Punch & Associates Investment Management

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Punch & Associates Investment Management from 13F filings

Historical chart of Punch & Associates Investment Management investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Punch & Associates Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Punch & Associates Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.7M 1.3M 6.50
2023-09-30 $11M 1.2M 9.44
2023-06-30 $14M 1.0M 13.97
2023-03-31 $15M 819k 18.76
2022-12-31 $11M 810k 13.77
2022-09-30 $16M 826k 19.12
2022-06-30 $9.6M 632k 15.26
2022-03-31 $13M 637k 20.37
2021-12-31 $18M 618k 29.18
2021-09-30 $16M 731k 21.57
2021-06-30 $20M 765k 25.65
2021-03-31 $14M 758k 18.23
2020-12-31 $8.6M 749k 11.54
2020-09-30 $2.9M 381k 7.62